Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1994-01-31
1998-03-17
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242361, A61K 39085, A61K 3909
Patent
active
057283885
ABSTRACT:
Treatment of solid tumors, including their metastases, without radiation, surgery or standard chemotherapeutic agents is described. Ex vivo stimulation of cells, selection of specific V.beta. subsets of stimulated cells and reinfusion of the V.beta. subsets of stimulated cells is employed for cancer therapy.
REFERENCES:
patent: 4400376 (1983-08-01), Sanderson
patent: 4478823 (1984-10-01), Sanderson
patent: 4624846 (1986-11-01), Goldenberg
patent: 4681870 (1987-07-01), Balint, Jr. et al.
patent: 5041289 (1991-08-01), Phillips
patent: 5192537 (1993-03-01), Osband
Grossman et al, The Journal of Immunology 144:3274-3281, 1991.
Metzroth et al, Infect & Immunity 61:2445-2452 1993.
Unconventional Cover Treatment--p. 226-235 Chape 12.
Morecki et al J. Biol Response Modif 9:463-474 1990.
Newell et al PNAS 88:1074-1078 1991.
Chang et al Cancer Res 53:1043-1050 1993.
Travis Science 258:1732-1733, 1992.
Rockwell Rodent Tumor Models in Exp. Cancer Therapy, Chapter 7 pp. 29-36 1987.
Siemon Rodent Tumor Models in Exp. Cancer Therapy Chapter 3 pp. 12-15 1987.
Trott et al Rodent Tumor Models in Exp Cancer Therapy Chapter 2 6-11 1984.
Das et al. (1989) J. Immunology vol. 142(8):2943-2948.
Boon, T., "Teaching the Immune System to Fight Cancer", Scientific American, pp. 82-89, Mar. 1993.
Chou, T., et al., "Generation of Therapeutic T Lymphocytes From Tumor-Bearing Mice by In Vitro Sensitization", The Journal of Immunology, vol. 140, No. 7, pp. 2453-2461, Apr. 1, 1988.
Garcia-Penarrubia, P., et al., "Selective Proliferation of Natural Killer Cells among Monocyte-Depleted Peripheral Blood Mononuclear Cells as a Result of Stimulation with Staphylococcal Enterotoxin B", Infection and Immunity, vol. 57, No. 7, pp. 2057-2065, Jul. 1989.
Kappler, J., et al., "V.beta.-Specific Stimulation of Human T Cells by Staphylococcal Toxins", Science, vol. 244, pp. 811-813, May 19, 1989.
Kartner, N. and Ling, V., "Multidrug Resistance in Cancer", Scientific American, pp. 44-51, Mar. 1989.
Maghazachi, A., and Fitzgibbon, L., "Fate of Intravenously Administered Rat Lymphokine-Activated Killer Cells Labeled with Different Markers", Cancer Immunology Immunotherapy, vol. 31, pp. 139-145, 1990.
Nicholson, G., "Growth Mechanisms and Cancer Progression", Hospital Practice, pp. 43-53, Feb. 15, 1993.
Rosenberg, S., et al., "Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer", New England Journal of Medicine, vol. 313, No. 23, pp. 1484-1492, Dec. 5, 1985.
Shcheglovitova, O.N., et al., "Effect of Staphyl-ococcal Enterotoxin A-Sensitized Spleen Cells on Metastasizing of Mouse Lewis Carcinoma", Eksp Onkol, vol. 11, No. 2, pp. 54-57, 1989.
Shu, S., et al., "Adoptive Immunotherapy of Newly Induced Murine Sarcomas", Cancer Research, vol. 45, pp. 1657-1662, Apr. 1985.
Shu, S., et al., "In Vitro Sensitization and Expan-sion With Viable Tumor Cells and Interleukin 2 in the Generation of Specific Therapeutic Effector Cells", The Journal of Immunology, vol. 136, No. 10, pp. 3891-3898, May 15, 1986.
Shu, S., et al., "Lymphocytes Generated by In Vivo Priming and In Vitro Sensitization Demonstrate Therapeutic Efficacy Against A Murine Tumor That Lacks Apparent Immunogenicity", The Journal of Immunology, vol. 143, No. 2, pp. 740-748, Jul. 15, 1989.
Shu, S., et al., "Stimulation of Tumor-Draining Lymph Node Cells with Superantigenic Staphylococcal Toxins Leads to the Generation of Tumor-Specific Effector T Cells", The Journal of Immunology, pp. 1277-1288, 1994.
Spero, L., "Biological Activities of the Peptides of Staphylococcal Enterotoxin C Formed by Limited Tryp-tic Hydrolysis", The Journal of Biological Chemistry, vol. 253, No. 24, pp. 8787-8791, Dec. 25, 1978.
Yoshizawa, H., et al., "Activation by Anti-CD3 of Tumor-Draining Lymph Node Cells for Specific Adoptive Immunotherapy", Cellular Immunology, vol. 134, pp. 473-479, 1991.
P. Calabresi and B. Chambner, "Chemotherapy of Neoplastic Disease," in The Pharmacological Basis of Therapeutics, 8th Edition (Goodman and Gilman, Eds., Pergamon Press), Sect. XII Introd. pp. 1202-1208.
P. Calabresi and B. Chabner, "Antineoplastic Agents," in The Pharmacological Basis of Therapeutics, 8th Edition (Goodman and Gilman, Eds., Pergamon Press), Chap. 52, pp. 1209-1216.
J. Gerlach et al., "Multidrug Resistance," Cancer Surveys 5:25-46 (1986).
J. Goldie and A. Coldman, "The Genetic Origin of Drug Resistance in Neoplasms: Implications for Systemic Therapy," Cancer Res. 44:3643-53 (1984).
V. DeVita, Jr., "The Relationship Between Tumor Mass and Resistance to Chemotherapy," Cancer 51:1209-1220 (1983).
M. Gottesman and I. Pastan, "Resistance to Multiple Chemotherapeutic Agents in Human Cancer Cells," Trends Pharmacol. Sci., 9:54-58 (1988).
S. Shu et al., "Generation From Tumor-Bearing Mice of Lymphocytes With in vivo Therapeutic Efficacy," J. Immunol., 139:295-304 (1987).
B. Ward et al., "Cellular Basis of Immunologic Interactions in Adoptive T Cell Therapy of Established Metastases From a Syngeneic Murine Sarcoma," J. Immunol., 141:1047-53 (1988).
T. Chou et al., "Adoptive Immunotherapy of Microscopic and Advanced Visceral Metastases With in vitro Sensitized Lymphoid Cells From Mice Bearing Progressive Tumors," J. Immunol., 141:1775-81 (1988).
H. Yoshizawa et al., "Specific Adoptive Immunotherapy Mediated by Tumor-Draining Lymph Node Cells Sequentially Activated With Anti-CD3 and IL-2," J. Immunol., 147:729-37 (1991).
F.S. Chu et al., "Purification and Characterization of Staphylococcal Enterotoxin A," Biochemistry, 5:3281-3289 (1966).
M. Bergdoll et al., "Identification of a New Enterotoxin as Enterotoxin C," Bacteriol., 90:1481-1485 (1965).
C. Borja and M. Bergdoll, "Purification and Partial Characterization of Enterotoxin C Produced by Staphylococcus aureus Strain 137," Biochem., 6:1467-1473 (1967).
R. Avena and M. Bergdoll, "Purification and Some Physicochemical Properties of Enterotoxin C, Staphylococcus aureus Strain 361," Biochem., 6:1474-1480 (1967).
E. Schantz et al., "Purification and Some Chemical and Physical Properties of Staphylococcal Enterotoxin A," Biochem., 11:360-366 (1972).
E. Schantz et al., "Purification of Staphylococcal Enterotoxin B," Biochem., 4:1011-1016 (1965).
H-C. Chang and M. Bergdoll, "Purification and Some Physicochemical Properties of Staphylococcal Enterotoxin D," Biochem., 18:1937-1942 (1979).
C. Borja et al., "Purification and Some Physicochemical Properties of Staphylococcal Enterotoxin E,"J. Biol. Chem., 247:2456-2463 (1972).
Data Section In: Atlas of Protein Sequence Structure 5:D227 (M. Dayhoff, ed.), Nat'l. Biomed. Research Found., Washington D.C. (1972).
I. Huang and M. Bergdoll, "The Primary Structure of Staphylococcal Enterotoxin B," J. Biol. Chem., 245:3493-3511 (1970).
M. Bergdoll et al., "Enterotoxin Synthesis by the Staphylococci," In Recent Advances in Staphylococcal Research (W.W. Yotis, ed.), Ann. N.Y. Acad. Sci., 236:307-16.
J. Iandolo, "Genetic Analysis of Extracellular Toxins of Staphylococcus aureus," Ann. Rev. Microbiol.,43:375-402 (1989).
M. Bergdoll et al., "Staphylococcal Enterotoxin B, III. The Physicochemical Properties and the N-and C-Terminal Amino Acid Sequences," Arch. Biochem. Biophys., 112:104-110 (1965).
I. Huang et al., "Amino Acid Composition and Terminal Amino Acids of Staphylococcal Enterotoxin C," Biochem., 6:1480-1484 (1967).
M. Bergdoll et al., "Chemistry of the Staphylococcal Enterotoxins," J. Agric. Food Chem., 22:9-13 (1974).
D. Blomster-Hautamaa et al., "Preparation of Toxic Shock Syndrome Toxin-1," Methods Enzymol., 165:37-43 (1988).
L. Johnson et al., "Streptococcal Pyrogenic Exotoxin Type A (Scarlet Fever Toxin) is Related to Staphylococcus aureus Enterotoxin B," Mol. Gen. Genet., 203:354-56 (1986).
W. Pearson and D. Lipman, "Improved Tools For Biological Sequence Comparison," Proc. Nat'l Acad. Sci., (USA) 85:2444-48 (1988).
D. Lipman and W. Pearson, "Rapid and Sensitive Protein Similarity Searches," Science 227:1435-41 (1985).
D. Terman et al., "Preliminary Observations of the Effects of Breast Adenocarcinoma of Plasma P
Cech Emma
Haliday Emily M.
Schwartz Richard A.
Terlizzi Laura
LandOfFree
Method of cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of cancer treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-955443